CorrectSequence Therapeutics
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Distrct Shanghai No.99 Haike Rd, Pudong,...Website
www.correctsequence.comRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About CorrectSequence Therapeutics
CorrectSequence Therapeutics is a pharmaceutical company specializing in innovative gene editing technologies, particularly base editing and gene therapy. Their mission is to help individuals suffering from severe diseases by providing advanced treatment solutions. The company aims to be a leading player in the gene editing field, both in China and globally. They focus on patient-centered values, emphasizing responsibility, collaboration, and innovation in their approach.Explore more
CorrectSequence Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CorrectSequence Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CorrectSequence Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at CorrectSequence Therapeutics
Funding: Get notified immidiatlly once CorrectSequence Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if CorrectSequence Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on CorrectSequence Therapeutics recently announced quarterly report
CorrectSequence Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if CorrectSequence Therapeutics is spiking on competitors!
Product Launch: Get notified when CorrectSequence Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined CorrectSequence Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
CorrectSequence Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CorrectSequence Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CorrectSequence Therapeutics.
CorrectSequence Therapeutics Tech Stack
A closer look at the technologies used by CorrectSequence Therapeutics
CorrectSequence Therapeutics News & Media
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 5, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a...High-Precision Base Editing Clinical Treatment for Sickle Cell Disease -- CorrectSequence Therapeutics' CS-101 Achieves Promising Results in First Patient
SHANGHAI, Aug. 26, 2025 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, today announced the successful treatment of the first sickle cell...OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics
SHANGHAI, Aug. 6, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion-dependent β-thalassemia. Utilizing their pioneering transformer Base Editor (tBE), Correctseq has successfully cured the first overseas patient with transfusion-dependent β-thalassemia in a clinical trial in collaboration with the First Affiliated Hospital of Guangxi Medical University. The patient has achieved
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CorrectSequence Therapeutics
Sign Up For FreeTo access detailed company insights
CorrectSequence Therapeutics is a pharmaceutical company specializing in innovative gene editing technologies, particularly base editing and gene therapy. Their mission is to help individuals suffering from severe diseases by providing advanced treatment solutions. The company aims to be a leading player in the gene editing field, both in China and... Read More
